Pages that link to "Q24200657"

The following pages link to Neuroprotection for treatment of glaucoma in adults (Q24200657):

Displaying 24 items.

• Neuroprotection in Glaucoma (Q26740388) (← links)
• Neuroprotection as a Therapeutic Target for Diabetic Retinopathy (Q26749178) (← links)
• Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma (Q26752575) (← links)
• Novel therapies for open-angle glaucoma (Q26851132) (← links)
• Stem cells, retinal ganglion cells and glaucoma (Q26860040) (← links)
• Neuroprotection for treatment of glaucoma in adults. (Q30238789) (← links)
• The treatment methods for post-stroke visual impairment: A systematic review (Q33695324) (← links)
• Choice of Stimulus Range and Size Can Reduce Test-Retest Variability in Glaucomatous Visual Field Defects (Q34443829) (← links)
• Pharmacotherapy of glaucoma (Q35138049) (← links)
• Neuroprotective therapies for glaucoma. (Q38384978) (← links)
• Biochemical changes and treatment in glaucoma (Q38443580) (← links)
• Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions (Q38584194) (← links)
• Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy (Q38873909) (← links)
• Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial (Q41657633) (← links)
• Brimonidine Can Prevent In Vitro Hydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal Müller Cells. (Q45935732) (← links)
• The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice. (Q48190647) (← links)
• In Vivo Scanning Laser Confocal Microscopy of Conjunctival Goblet Cells in Medically-controlled Glaucoma (Q51748290) (← links)
• Impact of Different Visual Field Testing Paradigms on Sample Size Requirements for Glaucoma Clinical Trials. (Q52646071) (← links)
• Translational Pharmacology in Glaucoma Neuroprotection. (Q53842256) (← links)
• Neuroprotective agents in the management of glaucoma. (Q55278853) (← links)
• GCDB: a glaucomatous chemogenomics database for in silico drug discovery (Q58132502) (← links)
• Therapeutic potential of valproic acid in advanced glaucoma: A pilot study (Q58806252) (← links)
• European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options (Q88187653) (← links)
• Improving the Feasibility of Glaucoma Clinical Trials Using Trend-Based Visual Field Progression Endpoints (Q97426747) (← links)